4.3 Article

Hyperglycemia and advanced glycation end products (AGEs) suppress the differentiation of 3T3-L1 preadipocytes

Journal

ONCOTARGET
Volume 8, Issue 33, Pages 55039-55050

Publisher

IMPACT JOURNALS LLC
DOI: 10.18632/oncotarget.18993

Keywords

advanced glycation end products (AGEs); hyperglycemia; adipogenesis; NF-kappa B; Bcl-2

Funding

  1. Ministry of Science and Technology [MOST 104-2320-B-400-008, 105-2314-B-371-005]
  2. National Health Research Institutes [CS-PP03]

Ask authors/readers for more resources

Aging is characterized by mild hyperglycemia and accumulation of advanced glycation end products (AGEs). Effects of chronic exposure to hyperglycemia or AGEs on the adipogenic differentiation of 3T3-L1 preadipocytes remain unclear. We examined the chronic effect of AGEs and high glucose on the differentiation of 3T3-L1 cells by culturing 3T3-L1 cells in the presence of AGEs or 25 mM glucose for 1 month. Chronic incubation of 3T3-L1 cells with AGEs or high glucose blocked their differentiation into mature adipocytes as evidenced by reduced levels of adipocyte markers such as accumulated oil droplets, GPDH, aP2, adiponectin and of adipogenesis regulators PPAR. and C/EBPa. Levels or activities of Src, PDK1, Akt, and NF-kappa B were higher in AGEs- and high glucose-treated cells than those in 3T3-L1 cells. Levels of Bcl-2 were elevated in AGEs- and high glucose-treated cells, and were attenuated by inhibitors of PI3-kinase, Akt and NF-kappa B. Moreover, adipogenesis was attenuated in 3T3-L1 cells stably expressing Bcl-2 or YAP. These results suggest that chronic AGEs and high glucose treatments up-regulate Bcl-2 and YAP via the Akt- NF-kappa B pathway and impair adipogenesis.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.3
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available